Alcon eye drops for glaucoma approved

Alcon’s Simbrinza eye drops suspension has been approved by the European Commission to decrease elevated intraocular pressure in adult patients with open-angle glaucoma or ocular hypertension.

The company said that Simbrinza  provided a convenient option to reduce treatment burden versus concomitant administration of single drugs.

Jeff George, global head of Alcon, said: ‘We are pleased to introduce the only fixed combination therapy without a beta-blocker to help more glaucoma patients manage their progressive eye condition.’